WA
Wasatch Advisors’s C4 Therapeutics CCCC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.6M | Buy |
7,424,662
+700,253
| +10% | +$1M | 0.06% | 154 |
|
|
2025
Q1 | $10.8M | Buy |
6,724,409
+651,808
| +11% | +$1.04M | 0.06% | 155 |
|
|
2024
Q4 | $21.9M | Buy |
6,072,601
+395,233
| +7% | +$1.42M | 0.11% | 130 |
|
|
2024
Q3 | $32.4M | Buy |
5,677,368
+830,218
| +17% | +$4.73M | 0.16% | 114 |
|
|
2024
Q2 | $22.4M | Buy |
4,847,150
+518,671
| +12% | +$2.4M | 0.12% | 123 |
|
|
2024
Q1 | $35.4M | Sell |
4,328,479
-2,810,470
| -39% | -$23M | 0.18% | 109 |
|
|
2023
Q4 | $40.3M | Buy |
7,138,949
+891,808
| +14% | +$5.04M | 0.22% | 101 |
|
|
2023
Q3 | $11.6M | Sell |
6,247,141
-952,350
| -13% | -$1.77M | 0.07% | 137 |
|
|
2023
Q2 | $19.8M | Buy |
7,199,491
+1,483,470
| +26% | +$4.08M | 0.12% | 129 |
|
|
2023
Q1 | $17.9M | Sell |
5,716,021
-59,677
| -1% | -$187K | 0.11% | 137 |
|
|
2022
Q4 | $34.1M | Sell |
5,775,698
-158,778
| -3% | -$937K | 0.23% | 97 |
|
|
2022
Q3 | $52M | Buy |
5,934,476
+267,818
| +5% | +$2.35M | 0.36% | 75 |
|
|
2022
Q2 | $42.7M | Buy |
5,666,658
+4,128,133
| +268% | +$31.1M | 0.27% | 94 |
|
|
2022
Q1 | $37.3M | Buy |
1,538,525
+243,063
| +19% | +$5.9M | 0.18% | 110 |
|
|
2021
Q4 | $41.7M | Sell |
1,295,462
-46,585
| -3% | -$1.5M | 0.17% | 120 |
|
|
2021
Q3 | $60M | Sell |
1,342,047
-47,442
| -3% | -$2.12M | 0.24% | 102 |
|
|
2021
Q2 | $52.6M | Buy |
1,389,489
+304,482
| +28% | +$11.5M | 0.21% | 100 |
|
|
2021
Q1 | $40.1M | Buy |
+1,085,007
| New | +$40.1M | 0.18% | 109 |
|